title: Efficacy of cognitive-behavioral and pharmacological treatments for children with social anxiety.
abstract: Childhood social anxiety is associated with significant social and academic impairment. The purpose of this study was to compare and contrast the efficacy of two major treatments for social anxiety disorders in children: cognitive-behavioral therapy and selective serotonin reuptake inhibitor (SSRI) drug treatment. Treatment studies in the literature were evaluated using meta-analytic techniques to compare pre- and post-treatment measures of social anxiety symptoms, general anxiousness, social competency, and impairment. Results indicate that the core symptoms of social anxiety and impairment were reduced by both cognitive-behavioral treatment (ES=0.86 and 1.56) and SSRI treatment (ES=1.30 and 2.29), respectively. Similarly, peripheral symptoms of general anxiousness were reduced by both cognitive-behavioral treatment (ES=0.75) and SSRI treatment (ES=1.29). Finally, both cognitive-behavioral (ES=0.68) and SSRI treatment (ES=0.68) resulted in moderate improvements in social competence. Implications and the limitations of these meta-analytic findings are discussed with respect to the evidence-based intervention movement.
authors.affiliation: Department of Counseling, Educational Psychology, and Special Education, College of Education, Michigan State University, East Lansing, Michigan 48824, USA. segoolna@msu.edu
authors.forename: Natasha K
authors.initials: NK
authors.lastname: Segool
authors.forename: John S
authors.initials: JS
authors.lastname: Carlson
mesh_terms: D002648:Child; D015928:Cognitive Behavioral Therapy; D006801:Humans; D010698:Phobic Disorders / Q000175:diagnosis / Q000523:psychology / Q000628:therapy*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D012917:Social Adjustment; D016896:Treatment Outcome
chemical_list: D017367:Selective Serotonin Reuptake Inhibitors